BTA 0.00% 57.0¢ biota holdings limited

niman knows more than who, page-7

  1. 426 Posts.
    lightbulb Created with Sketch. 10
    Dear All,
    Further Commentary from DR Niman at Recombinomics on the debate with WHO and CDC (US Centres for Disease Control) regarding the D225G/N Virulence Factor association with fatal cases and the selection of a vaccine strain which may not be protective.

    This is a matter of serious concern.

    I would put my money on Niman.

    This is an important issue in relation to Biota and ensuiring an adequate supply of Relenza

    Regards
    Kangaroo1

    http://www.recombinomics.com/whats_new.html

    CDC Comments Raise H1N1 D225G/N Surveillance Concerns
    Recombinomics Commentary 15:46
    March 8, 2010

    CDC In Denial On H1N1 D225G/N Significance
    Recombinomics Commentary 23:16
    March 7, 2010

    CDC Reliance on Negative D225G/N Data Raises H1N1 Concerns
    Recombinomics Commentary 19:32
    March 7, 2010

    CDC On D225G In Egg Isolates Raises H1N1 Vaccine Concerns
    Recombinomics Commentary 14:58
    March 7, 2010







 
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.